About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiology
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
Anticoagulant Reversal Agents
By
George Davis
0 views
August 1, 2017
Comments
2
Login to view comments.
Click here to Login
Recommended
AUTOPLAY
ON
19:49
Rush University Medical Center
COVID-19 Coagulopathy: Whom to Anticoagulate and How? What Agents to…
Feat.
S. Jain
14:39
Lankenau
Management of AF patients with ACS
Feat.
P. Kowey,
D. Ice
18:36
The Texas Heart Institute
Rhythm vs Rate: Has the Tide Changed Since the AFFIRM Trial?
Feat.
M. Razavi
57:30
McMaster University Department of Medicine
Five Things Every Internist Should Know About Anticoagulants
Feat.
S. Mithoowani
48:35
Houston Methodist DeBakey Heart and Vascular Center
"Pill in Pocket" Anticoagulation for Atrial Fibrillation: …
Feat.
R. Passman
21:17
Venous Edge
Acute DVT: When to and When Not to Intervene?
Feat.
S. Elias,
C. Pena,
C. Huff,
R. Winokur,
K. BROWN
12:30
Taya Glotzer
Management of Device Detected AF
14:44
Stanford Medicine
How Much Atrial Fibrillation Is Too Much: Contemporary and Future Ma…
Feat.
A. Perino
08:29
PERT Consortium 2022
Duration of Anticoagulation: Provoked vs Unprovoked VTE
Feat.
G. Barnes
16:11
Jeffrey Weitz
Extended Anticoagulation for VTE
10:21
NY Endovascular Summit
Medical Management of DVT
Feat.
J. Goldfinger
17:24
Canadian Collaborative Research Network
Are Factor XI/XIa Inhibitors the Future of Stroke Prevention?
Feat.
C. Ruff
14:16
Penn Medicine Heart and Vascular Center
Stroke Prevention in Atrial Fibrillation
Feat.
D. Goldberg
19:51
AHA 2023 Insights
AHA 2023 Insights: Apixaban for Stroke Prevention in Subclinical Atr…
Feat.
J. Healey
22:57
The France Foundation
Insights into Advances in Nonvalvular Atrial Fibrillation: Exploring…
Feat.
C. Ruff,
J. Walker
19:47
Complex Coronary Cases
Therapy Post PCI: What Is the Rationale for DAPT and OAC? When to Us…
Feat.
U. Baber
14:47
ACC 2023 Conference Coverage
ACC 2023: Can LAAC Be Considered a True Alternative to OAC?
Feat.
A. Natale
15:49
PERT Consortium 2021
VTE Prevention in Medical Patients
Feat.
S. Schulman
34:40
Icahn School of Medicine at Mount Sinai
Peri-Operative Management of Anticoagulation
Feat.
A. Dunn
11:08
The North American Thrombosis Forum (NATF)
Case Presentation: What Anticoagulant a Hematologst Recommends to an…
Feat.
T. Wang